Scarica l'app Stockscreener
111.38
1.79%
-2.03
Dopo l'orario di chiusura:
111.37
-0.010
-0.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$113.41
Aprire:
$113.9
Volume 24 ore:
9.97M
Relative Volume:
1.03
Capitalizzazione di mercato:
$275.09B
Reddito:
$65.51B
Utile/perdita netta:
$8.93B
Rapporto P/E:
31.35
EPS:
3.5532
Flusso di cassa netto:
$14.12B
1 W Prestazione:
+0.00%
1M Prestazione:
-5.53%
6M Prestazione:
+19.87%
1 anno Prestazione:
+48.90%
Intervallo 1D:
$110.94
$113.93
Intervallo di 1 settimana:
$110.94
$114.06
Portata 52W:
$74.37
$125.14
Merck Co Inc Stock (MRK) Company Profile
Nome
Merck Co Inc
Settore
Industria
Telefono
908-740-4000
Indirizzo
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, NVS, AZN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
111.38 | 280.10B | 65.51B | 8.93B | 14.12B | 3.5532 |
LLY
Lilly Eli Co
|
1,004.92 | 897.72B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
226.71 | 555.59B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
210.39 | 372.39B | 62.82B | 3.60B | 19.98B | 2.0274 |
NVS
Novartis Ag Adr
|
148.08 | 285.77B | 54.66B | 13.58B | 16.05B | 7.0171 |
AZN
Astrazeneca Plc
|
181.58 | 286.84B | 60.48B | 10.40B | 8.05B | 3.3297 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-02-20 | Iniziato | Barclays | Overweight |
| 2026-02-13 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2026-01-08 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-10-13 | Ripresa | Citigroup | Neutral |
| 2025-09-17 | Downgrade | Berenberg | Buy → Hold |
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-08 | Downgrade | Truist | Buy → Hold |
| 2024-12-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Ripresa | BofA Securities | Buy |
| 2024-12-04 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-11 | Downgrade | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-03-11 | Downgrade | Societe Generale | Hold → Sell |
| 2024-01-04 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-27 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Hold |
| 2023-04-13 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-03-28 | Downgrade | Societe Generale | Buy → Hold |
| 2023-03-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Iniziato | Jefferies | Buy |
| 2023-02-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-10-10 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-09-14 | Aggiornamento | Berenberg | Hold → Buy |
| 2022-07-06 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Ripresa | SVB Leerink | Outperform |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Iniziato | Goldman | Buy |
| 2021-12-16 | Iniziato | Daiwa Securities | Neutral |
| 2021-12-13 | Downgrade | UBS | Buy → Neutral |
| 2021-12-09 | Iniziato | Wells Fargo | Overweight |
| 2021-12-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-11-29 | Downgrade | Citigroup | Buy → Neutral |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Aggiornamento | Argus | Hold → Buy |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-05-20 | Downgrade | Argus | Buy → Hold |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-08-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-06-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-16 | Iniziato | SVB Leerink | Outperform |
| 2019-07-03 | Iniziato | Mizuho | Buy |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-05-13 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Reiterato | Citigroup | Buy |
| 2018-10-09 | Ripresa | Guggenheim | Buy |
| 2018-04-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-04-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-07 | Reiterato | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Merck Co Inc Borsa (MRK) Ultime notizie
Merck & Co., Inc. stock (US58933Y1055): Keytruda momentum and fresh earnings keep big pharma in focu - AD HOC NEWS
Financial Security Advisor Inc. Raises Holdings in Merck & Co., Inc. $MRK - MarketBeat
Lockheed Martin Investment Management Co. Has $9.87 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Convergence Investment Partners LLC - MarketBeat
Merck & Co., Inc. $MRK Stake Reduced by ANTIPODES PARTNERS Ltd - MarketBeat
Merck & Co. Inc. stock underperforms Friday when compared to competitors - MarketWatch
Merck & Co. Inc. stock (US58933Y1055): Key cancer franchise drives fresh earnings spotlight - AD HOC NEWS
Cancer Centers Race To Access Revolution Medicines' Pancreatic Cancer Treatment: Report - Benzinga
Merck & Co., Inc. stock (US58933Y1055): pharma giant doubles down on M&A as investors eye post-Keytr - AD HOC NEWS
Merck & Co., Inc. $MRK Stock Holdings Increased by Phoenix Financial Ltd. - MarketBeat
Merck & Co., Inc. $MRK is Conning Inc.'s 5th Largest Position - MarketBeat
Bessemer Group Inc. Increases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Allworth Financial LP Grows Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. stock (US58933Y1055): Latest developments and business overview - AD HOC NEWS
Merck & Co. Inc. stock (US58933Y1055): Latest developments and business overview - AD HOC NEWS
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
World Investment Advisors Buys 20,067 Shares of Merck & Co., Inc. $MRK - MarketBeat
Rayburn West Financial Services LLC Takes $1.17 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Summit Wealth Group LLC Co. Has $522,000 Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Bank Julius Baer & Co. Ltd Zurich Buys 100,280 Shares of Merck & Co., Inc. $MRK - MarketBeat
Top Companies in Hospital Acquired Infection Treatment MarketMerck & Co Inc, Pfizer Inc, Cipla Ltd etc. - openPR.com
Merck & Co. Inc. stock (US58933Y1055): Q1 results show revenue growth amid Keytruda strength - AD HOC NEWS
Merck & Co., Inc. stock (US58933Y1055): Q1 beat and upgraded 2026 guidance drive 8% jump - AD HOC NEWS
Merck & Co. Inc. stock (US58933Y1055): Q1 earnings beat with revenue growth - AD HOC NEWS
Merck's (NYSE:MRK) Soft Earnings Are Actually Better Than They Appear - Moomoo
VIRGINIA RETIREMENT SYSTEMS ET Al Reduces Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Lifted by Independent Advisor Alliance - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Money Concepts Capital Corp - MarketBeat
MRK Stock Quote Price and Forecast - CNN
Merck & Co., Inc. (MRK) 10K Form and Latest SEC Filings 2026 - MarketBeat
Analyst Reinstates Merck (MRK) with ‘Neutral’ Rating, $125 Price Target - Insider Monkey
Merck & Co. stock (US58933Y1055): Oncology portfolio advances at ASCO 2026 - AD HOC NEWS
The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex - Zacks Investment Research
Merck (MRK) Tops Quarterly Sales Forecasts as Keytruda Drives Growth - Insider Monkey
Top Research Reports for UnitedHealth, Merck & Qualcomm - Yahoo Finance Singapore
Merck stock (US58933Y1055): Q1 earnings beat, revenue guidance narrowed - AD HOC NEWS
Merck & Co., Inc. stock (US58933Y1055): Q1 earnings beat with revenue growth - AD HOC NEWS
Merck & Co., Inc. $MRK Shares Sold by SVB Wealth LLC - MarketBeat
Swiss Life Asset Management Ltd Raises Position in Merck & Co., Inc. $MRK - MarketBeat
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ERAS-0015 in Combination with KEYTRUDA® (Pembrolizumab) - The Manila Times
Investors Can Find Comfort In Merck's (NYSE:MRK) Earnings Quality - Yahoo Finance Singapore
Securian Asset Management Inc. Has $7.10 Million Position in Merck & Co., Inc. $MRK - MarketBeat
NewEdge Wealth LLC Has $9.33 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by ABN AMRO Bank N.V. - MarketBeat
Osprey Private Wealth LLC Raises Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Applied Finance Dividend Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
Bryn Mawr Trust Advisors LLC Has $24.27 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck 1Q Januvia/Janumet Sales $574M >MRK - Moomoo
Merck & Co. Inc. stock (US58933Y1055): Earnings beat and pipeline update drive investor interest - AD HOC NEWS
Wesbanco Bank Inc. Sells 17,179 Shares of Merck & Co., Inc. $MRK - MarketBeat
Manning & Napier Advisors LLC Decreases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc Azioni (MRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):